Suchergebnisse - Sunfa Cheng
- Treffer 1 - 18 von 18
-
1
-
2
-
3
Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury von Sunfa Cheng, Allan S. Pollock, Rajeev Mahimkar, Jean L. Olson, David H. Lovett, Sunfa Cheng, Allan S. Pollock, Rajeev Mahimkar, Jean L. Olson, David H. Lovert
Veröffentlicht 2006Artigo -
4
A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodi... von Marina Bergman, Sunfa Cheng, Norman Honbo, Lucia Piacentini, Joel S. Karliner, David H. Lovett
Veröffentlicht 2003Artigo -
5
-
6
-
7
Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double‐blind, placebo‐controlled study von Takao Takeshima, Fumihiko Sakai, Koichi Hirata, Noboru Imai, Yasuhiko Matsumori, Ryuji Yoshida, Cheng Peng, Sunfa Cheng, Daniel D. Mikol
Veröffentlicht 2021Artigo -
8
Cinacalcet Reduces Serum Calcium Concentrations in Patients with Intractable Primary Hyperparathyroidism von Claudio Marcocci, Philippe Chanson, Dolores Shoback, John P. Bilezikian, Laureano Fernández‐Cruz, Jacques Orgiazzi, Christoph Henzen, Sunfa Cheng, Lulu Ren Sterling, John Lu, Munro Peacock
Veröffentlicht 2009Artigo -
9
-
10
Erenumab in chronic migraine von Richard B. Lipton, Stewart J. Tepper, Uwe Reuter, Stephen D. Silberstein, Walter F. Stewart, Jon Nilsen, Dean Leonardi, Pooja Desai, Sunfa Cheng, Daniel D. Mikol, Robert Lenz
Veröffentlicht 2019Artigo -
11
Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial von Messoud Ashina, Peter J. Goadsby, Uwe Reuter, Stephen D. Silberstein, David W. Dodick, Fei Xue, Feng Zhang, Gabriel Paiva da Silva Lima, Sunfa Cheng, Daniel D. Mikol
Veröffentlicht 2021Artigo -
12
Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine von Messoud Ashina, Peter J. Goadsby, Uwe Reuter, Stephen D. Silberstein, David W. Dodick, Gregory A. Rippon, Jan Klatt, Fei Xue, Victoria Chia, Feng Zhang, Sunfa Cheng, Daniel D. Mikol
Veröffentlicht 2019Artigo -
13
Vascular safety of erenumab for migraine prevention von David Kudrow, Julio Pascual, Paul Winner, David W. Dodick, Stewart J. Tepper, Uwe Reuter, Frank Hong, Jan Klatt, Feng Zhang, Sunfa Cheng, Hernàn Picard, Osa Eisele, Julie Wang, Jonathan N. Latham, Daniel D. Mikol
Veröffentlicht 2019Artigo -
14
Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism von Geoffrey A. Block, David A. Bushinsky, Sunfa Cheng, John Cunningham, Bastian Dehmel, Tilman B. Drüeke, Markus Ketteler, Reshma Kewalramani, Kévin Martin, Sharon M. Moe, Uptal D. Patel, Justin Silver, Yan Sun, Hao Wang, Glenn M. Chertow
Veröffentlicht 2017Artigo -
15
Practice patterns on the management of secondary hyperparathyroidism in the United States: Results from a modified Delphi panel von David Henner, Beatrice Drambarean, Teresa Gerbeling, Jessica Kendrick, William T. Kendrick, Lisa Koester-Wiedemann, Thomas L. Nickolas, Anjay Rastogi, Anis Abdul Rauf, Brenda Dyson, Michael C. Singer, Pooja Desai, Kathleen M. Fox, Sunfa Cheng, William G. Goodman
Veröffentlicht 2025Artigo -
16
Early onset of efficacy with erenumab in patients with episodic and chronic migraine von Todd J. Schwedt, Uwe Reuter, Stewart J. Tepper, Messoud Ashina, David Kudrow, Gregor Broessner, Guy Boudreau, Peter McAllister, Thuy Vu, Feng Zhang, Sunfa Cheng, Hernàn Picard, Shihua Wen, Joseph M. Kahn, Jan Klatt, Daniel D. Mikol
Veröffentlicht 2018Artigo -
17
Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure von Karl Swedberg, James B. Young, Inder S. Anand, Sunfa Cheng, Akshay S. Desai, Rafael Díaz, Aldo P. Maggioni, John J.V. McMurray, Christopher O’Connor, Marc A. Pfeffer, Scott D. Solomon, Yan Sun, Michał Tendera, Dirk J. van Veldhuisen
Veröffentlicht 2013Artigo -
18
Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED‐HF study von Paul Welsh, Lei Kou, Changhong Yu, Inder S. Anand, Dirk J. van Veldhuisen, Aldo P. Maggioni, Akshay S. Desai, Scott D. Solomon, Marc A. Pfeffer, Sunfa Cheng, Lars Gullestad, Pål Aukrust, Thor Ueland, Karl Swedberg, James B. Young, Michael W. Kattan, Naveed Sattar, John J.V. McMurray
Veröffentlicht 2017Artigo
Suchwerkzeuge:
Ähnliche Schlagworte
Medicine
Internal medicine
Migraine
Pathology
Alternative medicine
Placebo
Adverse effect
Biology
Biochemistry
Cell biology
Chronic Migraine
Clinical trial
Hyperparathyroidism
Randomized controlled trial
Calcium
Chemistry
Cinacalcet
Clinical endpoint
Parathyroid hormone
Secondary hyperparathyroidism
Tolerability
Urology
Calcimimetic
Cardiology
Endocrinology
Extracellular matrix
Fibrosis
Gastroenterology
Gene
Heart failure